US EditionMerck & Co., Inc.’s (MRK) “Neutral” Rating Reiterated at Citigroup
Summary by ETF Daily News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Merck & Co., Inc.’s (MRK) “Neutral” Rating Reiterated at Citigroup
Citigroup reaffirmed their neutral rating on shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in a report issued on Wednesday, MarketBeat Ratings reports. They currently have a $84.00 price target on the stock, down from their previous price target of $115.00. MRK has been the topic of a number of other reports. Cantor […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
